Multiple Manufacturers

LABETALOL HCL

Manufacturer:

Multiple Manufacturers

Labetalol Hcl HCPCS:

J1921

HCPCS Code Descriptor:

Injection, labetalol hydrochloride (hikma) not therapeutically equivalent to j1820, 5 mg

Category:

J Code

Labetalol Hcl NDCs:

00143-9365-10, 00143-9366-10, 00143-9364-10, 00143-9363-10, 00641-6252-10, 00143-9623-01, 00143-9622-01, 00143-9320-01

Primary Type:

Cardiology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Labetalol Hcl:

LABETALOL HCL is a Cardiology drug manufactured by HIKMA PHARMACEUTICALS USA INC. and administered via the Intravenous route of administration. The J Code: J1921 is aligned to the drug LABETALOL HCL.

ACCESS PRICING AND MORE BY REGISTERING

J1921 Added Date:

July 1, 2023

J1921 Effective Date:

July 1, 2023

J1921 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Labetalol Hcl billing and coding information.
Our team did not identify a source for Labetalol Hcl patient assistance information. Please reach out to our team if you feel that this is a mistake.
LABETALOL HCL prescribing information can be found at the link below:
Information regarding LABETALOL HCL’s side effects can be found at MedlinePlus